PROVIDER PROFILE · NPI 1508031196

Nila De La Rosa

Nurse PractitionerNew York, NYI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

118

Beneficiaries

—

Total drug cost

$403K

Distinct drugs

Brand share

26.3%

Top prescribed drugs

Hydrocortisone41 claims

Levothyroxine Sodium23 claims

Prednisone23 claims

Binimetinib17 claims

Encorafenib14 claims

QUALITY · MIPS · 2024

Final MIPS score

90.8

Quality

91.8

Cost

75.2

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.66%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$124

Payment records

By payment type

Food and Beverage$124

REFERRAL NETWORK

Where Nila De La Rosa's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 2 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
NYU LANGONE HOSPITALS	29	105
Ruth Oratz Medical Oncology · New York, NY	14	95

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
NYU LANGONE HOSPITALS	21	87
Ruth Oratz Medical Oncology · New York, NY	17	114

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history